Compare PMVP & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMVP | ANTA |
|---|---|---|
| Founded | 2013 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.2M | 68.2M |
| IPO Year | 2020 | 2024 |
| Metric | PMVP | ANTA |
|---|---|---|
| Price | $1.26 | $2.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $4.00 | ★ $8.25 |
| AVG Volume (30 Days) | ★ 368.4K | 16.7K |
| Earning Date | 11-10-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $1.50 |
| 52 Week High | $1.91 | $10.60 |
| Indicator | PMVP | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 55.46 |
| Support Level | $1.24 | $2.12 |
| Resistance Level | $1.49 | $4.19 |
| Average True Range (ATR) | 0.09 | 0.28 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 28.30 | 96.09 |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.